Adial Pharmaceuticals (ADIL) Enterprise Value (2022 - 2024)
Adial Pharmaceuticals' Enterprise Value history spans 3 years, with the latest figure at -$5.2 million for Q3 2024.
- For Q3 2024, Enterprise Value changed N/A year-over-year to -$5.2 million; the TTM value through Sep 2024 reached -$5.2 million, changed N/A, while the annual FY2023 figure was -$2.8 million, 29.35% up from the prior year.
- Enterprise Value for Q3 2024 was -$5.2 million at Adial Pharmaceuticals, down from -$3.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.2 million in Q2 2023 and bottomed at -$12.7 million in Q1 2022.
- The 3-year median for Enterprise Value is -$4.5 million (2022), against an average of -$5.1 million.
- The largest annual shift saw Enterprise Value skyrocketed 86.7% in 2023 before it tumbled 169.91% in 2024.
- A 3-year view of Enterprise Value shows it stood at -$4.0 million in 2022, then rose by 29.35% to -$2.8 million in 2023, then plummeted by 84.09% to -$5.2 million in 2024.
- Per Business Quant, the three most recent readings for ADIL's Enterprise Value are -$5.2 million (Q3 2024), -$3.3 million (Q2 2024), and -$5.0 million (Q1 2024).